#ASCO24 strong biomarker work presented by Dr. Katherine Fuh for GOG 3059. Overall neg phase 3 but high AXL probably matters. What’s next

Honored to have been part of GOG 3059/ENGOT-Ov66 in plat resistant Ovarian Cancer. Extremely grateful for mentorship by ⭐️DrKatyMoore ⭐️- team effort to develop options for our patients- much work to be done in resistant OC The GOG Foundation Inc. #needfutureoptions #ASCO24

#WAGO2024 Day 1 - great to see friends and colleagues! Fantastic start to sharing research on Gynecologic Oncology #workingtogetherforpatients ⁦⁦Debra Richardson, M.D.⁩ ⁦Amanika⁩ ⁦⁦Mayo Clinic Comprehensive Cancer Center⁩ ⁦OU Health⁩ ⁦OU Health Stephenson Cancer Center⁩

Amplifying a just decision by our Supreme Court

📰🔥HOT OF THE PRESSES 🔥 📰Today the FDA granted approval ✅for durvalumab + carbo/taxol f/b durvalumab maintenance 💉in patients w/ dMMR, advanced/recurrent endometrial cancer. Congrats 🌟to SGO member Shannon Westin, MD, MPH, FASCO, The GOG Foundation Inc. & colleagues & AstraZeneca! #UCAM FdtnForWomensCancer

What a team DrKatyMoore and Shannon Westin, MD, MPH, FASCO bringing more treatment options for our patients with endometrial cancer - changing the way we practice! #gyncsm FdtnForWomensCancer

FDA approves pembro w/ chemo for primary adv or recurrent EC- more progress for patients! IO now std of care in all pts w/ #endometrial cancer frontline irrespective of mmr status! ⁦The GOG Foundation Inc.⁩ ⁦SGO⁩ ⁦NRG Oncology⁩ ⁦名生 千夏 ⁦⁦Ramez Eskander⁩ fda.gov/drugs/resource…

A paradigm shift 📈 in understanding 🤨 vulvovaginal melanoma as a distinct tumor type compared with cutaneous melanoma SGO IGCS International Society of Gynecologic Pathologists ESGO ACOG OncoAlert sciencedirect.com/science/articl…

Learn about the latest trial data presented at SGO, ESGO, and ASCO + discuss transformative studies & controversies in data interpretation. How to translate results in practice to provide best care for our patients. Engaging, interactive, and informative. . .

The crosstalk between macrophages and cancer cells potentiates pancreatic cancer cachexia pubmed.ncbi.nlm.nih.gov/38608702/ Incredible work by Dr. Min Li and colleagues at Stephenson Cancer Center. Cancer cachexia impacts cancer outcomes and survivorship. Patient centered basic science

Cancer Stage Compared With Mortality as End Points in Randomized Clinical Trials of Cancer Screening: A Systematic … pubmed.ncbi.nlm.nih.gov/38583868/ and nejm.org/doi/full/10.10… Hilary Robbins and her team outline the promise and pitfalls of multicancer detection assays. Both are a

❗️Important to take that 2cm margin of proximal IP ligament during risk-reducing BSO to avoid leaving residual microscopic ovarian tissue!

Join us for the Master Session: Endometrial Cancer: Changing the Landscape at #IGCS2024 📅 Friday, October 18, 2024 Don’t miss this exceptional event with global experts in gynecologic oncology. 👉 View all IGCS 2024 programs here: igcsmeeting.com/program-at-a-g…

Antibody drug conjugates are an exciting new therapy, but so far targeting folate receptor + ovarian cancer is limited to high grade. Here, we show that low grade ovarian cancers have the same % of folate receptor positivity. Next up: see if these treatments benefit patients!

This is the beginning- engineered cell therapy in solid tumors is here! I’m honored to lead SURPASS 3 evaluating engineered T cells targeting MAGEA4 expressing ovarian cancer- I hope we will see an encouraging signal here too! As always, indebted to our patient volunteers who do

Glucagon-like peptide-1 (GLP-1) receptor agonists for weight management: A review for the gynecologic oncologist SGO IGCS ESGO ASCO OncoAlert sciencedirect.com/science/articl…

🌟Fantastic 🌟 opportunity for early career scientists to jumpstart their GYN cancer research 🔬 🧬careers. FdtnForWomensCancer is offering MORE grant 💵 than ever! It’s a great time to become an FWC scholar. SGO Ginger J. Gardner Karen Lu Matt Powell Anil Sood Katherine Fuh MD PhD

Ovarian cancer risk was markedly increased among women with ovarian endometriomas and/or deep infiltrating endometriosis. This population may benefit from counseling regarding ovarian cancer risk/prevention. Endometriosis Typology and Ovarian Cancer Risk jamanetwork.com/journals/jama/…

September is #GynecologicCancerAwarenessMonth. I'm going to try and post one outstanding piece of research each day to highlight the brilliant work of many of my colleagues and friends - all to benefit the patients we strive to cure. Here is the first: NRGGY018. This study

Day 2 of #GynecologicCancerAwarenessMonth this is one of the manuscripts that blew my mind in 2023 and I still look at it. Garsed et al. Nature Genetics 2023 (link) rdcu.be/dSLDh What they have done (and I will post more from this group) as fully characterize short and